Induction with MEDA regimen and consolidation with Auto‐HSCT for stage IV NKTCL patients: A prospective multicenter study
C Liu, H Ding, Q Zhu, P Liu, Y Zhu… - … Journal of Cancer, 2022 - Wiley Online Library
Optimal treatment strategies for natural killer/T‐cell lymphoma (NKTCL) patients with stage
IV disease have not been well defined. In this prospective phase 2 study, we evaluated the …
IV disease have not been well defined. In this prospective phase 2 study, we evaluated the …
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma …
The aim of this study was to investigate the impact of the induction treatment with SMILE
(dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide) chemotherapy …
(dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide) chemotherapy …
[HTML][HTML] Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of …
Y Zhang, Y Liu, Z Xia, J Jin, K Xue, J Wang… - Annals Of …, 2021 - ncbi.nlm.nih.gov
Background To explore a more effective treatment strategy for newly diagnosed stage I and
II extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, we conducted a prospective …
II extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, we conducted a prospective …
Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy
XW Bi, WQ Jiang, WW Zhang, JJ Huang, Y Xia… - Annals of …, 2015 - Springer
The prognosis of advanced stage natural killer/T-cell lymphoma (NKTCL) remains relatively
disappointing, and the optimal treatment strategy for this disease has yet to be discovered …
disappointing, and the optimal treatment strategy for this disease has yet to be discovered …
DDGP followed by radiotherapy vs VIPD followed by radiotherapy in newly diagnosed early NK/T-cell lymphoma
L Zhang, C Shangguan, X Li, L Li, X Wang, X Fu… - Leukemia Research, 2022 - Elsevier
Purpose To explore the best treatment for early natural killer/T (NK/T)-cell lymphoma, we
compared the efficacy and safety of DDGP (pegaspargase, gemcitabine, cisplatin and …
compared the efficacy and safety of DDGP (pegaspargase, gemcitabine, cisplatin and …
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A …
L Zhang, Y Wang, X Li, L Li, X Wang… - … Journal of Cancer, 2021 - Wiley Online Library
To compare the efficacy and safety of radiotherapy (RT) and chemotherapy of
pegaspargase, gemcitabine, cisplatin and dexamethasone (DDGP) combined with RT in …
pegaspargase, gemcitabine, cisplatin and dexamethasone (DDGP) combined with RT in …
[HTML][HTML] Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma
Limited data exist on up-front autologous stem cell transplantation (ASCT) in extranodal
natural killer/T cell lymphoma (ENKTL). Sixty-two patients (43 men and 19 women) with …
natural killer/T cell lymphoma (ENKTL). Sixty-two patients (43 men and 19 women) with …
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory …
H Ding, J Chang, LG Liu, D Hu, WH Zhang… - International journal of …, 2015 - Springer
Extranodal natural killer/T cell lymphoma, nasal type (ENK/TCL), is an aggressive and rare
hematological malignancy. Patients with advanced and relapsed/refractory disease have …
hematological malignancy. Patients with advanced and relapsed/refractory disease have …
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in …
H Wang, ZJ Wuxiao, J Zhu, Z Wang, KF Wang… - Leukemia & …, 2015 - Taylor & Francis
Optimal chemotherapy regimen for Extranodal natural killer/T-cell lymphoma (ENKTL) has
not yet been defined. We retrospectively compared the outcome of 93 patients newly …
not yet been defined. We retrospectively compared the outcome of 93 patients newly …
Combination of gemcitabine, l-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural …
W Liang, W Wei-Da, X Zhong-Jun, Z Yu-Jing, X Jin… - Medical oncology, 2014 - Springer
Optimal treatment strategies for localized extranodal natural killer/T cell lymphoma (ENKTL)
have not been fully defined. We retrospectively compared the efficacy and safety of …
have not been fully defined. We retrospectively compared the efficacy and safety of …